Revenues for the three months ended September 30, 2006 were $3,096,288, compared to $3,372,870 for the same quarter in 2005. Revenues from the third quarter showed solid increases in commercial chemical sales, license fee revenues and technology development revenues, and decreases in development chemical sales and contract research revenues. The Company’s revenue mix continues to shift as its phosphorescent OLED (PHOLEDâ¢) technology is commercialized.
The Company reported a net loss of $2,943,287 (or $0.09 per share) for the quarter ended September 30, 2006, compared to a net loss of $2,979,140 (or $0.10 per share) for the same quarter in 2005.
Posted: Nov 07,2006 by Ron Mertens
